Shutterstock |
Hundreds of thousands of Polish patients must switch to new pharmaceutical therapies in January, in a move that is expected to save the Polish government as much as zł.1 billion, reports Rzeczpospolita.
The new list of reimbursable drugs (published on December 23) will be missing several items patients had been using. They will now have a choice between switching to cheaper equivalents and paying more at the pharmacy.
“The most revolutionary change is the limiting of medicines which will be subsidized by the state. There will be a thousand less subsidized medications than there have been up until now,” Wiesław Latuszek- Łukasiewicz, head of the medical website Medycyna Praktyczna, told Rzeczpospolita.
Read WBJ’s recent cover story on the controversial reform of Poland’s pharmaceutical industry here
From Warsaw Business Journal
Germany attracts Polish entrepreneurs
Top earners
Chinese-Polish business relations: A small window of opportunity
Company savings increasing
Ten steps to setting up a business in Poland











back
Go to top